MedPath

Gruppo Italiano Malattie EMatologiche dell'Adulto

🇮🇹Italy
Ownership
Private
Employees
-
Market Cap
-
Website

Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia

Conditions
Chronic Myeloid Leukemia
First Posted Date
2017-03-09
Last Posted Date
2019-03-21
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
337
Registration Number
NCT03075969
Locations
🇦🇹

Innsbruck Medical University, Innsbruck, Austria

🇺🇸

Winship Cancer Institute of Emory University, Emory, Georgia, United States

🇨🇳

Guangdong Medical University, Guangdong, China

and more 29 locations

Italian Registry on the Prevalence of IDH1/IDH2 Mutations in Patients With Acute Myeloid Leukemia

Completed
Conditions
AML, Adult
Interventions
Genetic: IDH mutation test performed at diagnosis or relapse until January 31st, 2019.
First Posted Date
2016-12-08
Last Posted Date
2022-01-04
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
388
Registration Number
NCT02986620
Locations
🇮🇹

AOU Policlinico G. Martino, Messina, Italy

🇮🇹

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano, Milano, Italy

🇮🇹

Università degli Studi di Padova - Ematologia ed Immunologia Clinica, Padova, Italy

and more 21 locations

Bosutinib in Elderly Chronic Myeloid Leukemia

Phase 2
Completed
Conditions
Chronic Myeloid Leukemia
Interventions
First Posted Date
2016-06-23
Last Posted Date
2023-02-03
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
65
Registration Number
NCT02810990
Locations
🇮🇹

Policlinico di Careggi, Firenze, Italy

🇮🇹

S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

🇮🇹

Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI, Ancona, Italy

and more 42 locations

D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia

Phase 2
Conditions
Acute Lymphoblastic Leukemia
Interventions
First Posted Date
2016-04-20
Last Posted Date
2018-03-22
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
60
Registration Number
NCT02744768
Locations
🇮🇹

Az.Ospedaliera S.G.Moscati, Avellino, Italy

🇮🇹

Ospedale Niguarda " Ca Granda" - SC Ematologia Blocco SUD, Ponti Est, Scala E, 4° piano, Milano, Italy

🇮🇹

Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli", Napoli, Italy

and more 31 locations

Sustained Treatment-free Remission in BCR-ABL+ Chronic Myeloid Leukemia

Phase 4
Conditions
Chronyc Myeloid Leukemia
Interventions
First Posted Date
2015-11-11
Last Posted Date
2022-01-20
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
450
Registration Number
NCT02602314
Locations
🇮🇹

S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy

🇮🇹

UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro, Bari, Italy

🇮🇹

Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia, Rimini, Italy

and more 79 locations

Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program

Completed
Conditions
Chronic Lymphocytic Leukemia
Interventions
First Posted Date
2015-10-21
Last Posted Date
2021-09-13
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
264
Registration Number
NCT02582320
Locations
🇮🇹

U.O.C. Ematologia - IRCCS Centro oncologico della Basilicata, Rionero in Vulture, Italy

🇮🇹

Policlinico Umberto I, Hematology Department - Sapienza, Rome, Italy

🇮🇹

Sezione di Ematologia Cancer Center Humanitas, Rozzano, Italy

and more 44 locations

Efficacy and Safety of Bendamustine Plus Rituximab in Chronic Lympocytic Leukemia

Completed
Conditions
Chronic Lymphocytic Leukemia
Interventions
First Posted Date
2015-07-08
Last Posted Date
2020-10-06
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
494
Registration Number
NCT02491398
Locations
🇮🇹

S.O.C. di Medicina Interna B - Ospedale - Cardinal Massaia di Asti, Asti, Italy

🇮🇹

ASL N.8 - Ospedale "A. Businco" - Struttura Complessa di Ematologia e CTMO, Cagliari, Italy

🇮🇹

Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi, Bologna, Italy

and more 38 locations

Retrospective Evaluation of CML Patients in the National Compassionate Program

Terminated
Conditions
Chronic Myeloid Leukemia
Philadelphia Positive
Interventions
First Posted Date
2015-05-19
Last Posted Date
2022-10-26
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
38
Registration Number
NCT02448095
Locations
🇮🇹

ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE, Lecce, Italy

🇮🇹

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano, Milano, Italy

🇮🇹

Azienda Ospedaliera "S.Gerardo", Monza, Italy

and more 7 locations

Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia

Phase 2
Completed
Conditions
Primacy Immune Thrombocytopenia
Interventions
First Posted Date
2015-03-31
Last Posted Date
2021-08-16
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
55
Registration Number
NCT02402998
Locations
🇮🇹

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico UOC Oncoematologia- Padiglione Marcora 2° piano, Milano, Italy

🇮🇹

Ospedale Niguarda " Ca Granda" - SC Ematologia Blocco SUD, Ponti Est, Scala E, 4° piano, Milano, Italy

🇮🇹

Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia, Roma, Italy

and more 11 locations

Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib

Phase 2
Terminated
Conditions
Chronic Myeloid Leukemia
Chronic Phase
Adults
Interventions
First Posted Date
2015-03-26
Last Posted Date
2025-01-17
Lead Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Target Recruit Count
14
Registration Number
NCT02398825
Locations
🇮🇹

Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi, Bologna, Italy

🇮🇹

Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi, Ancona, Italy

🇮🇹

Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto", Catania, Italy

and more 34 locations
© Copyright 2025. All Rights Reserved by MedPath